The seventh batch of national centralized drug procurement has been released, with an average price reduction of nearly 50%! There are 3 types of patients who will benefit
Pay attention to "Alzheimer's disease": The key to prevention and treatment has moved forward, and national key scientific research projects have been established in Nanjing